Betaxolol Hydrochloride/Chlorthalidone

盐酸倍他洛尔/氯噻酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBetaxolol Hydrochloride/Chlorthalidone
Drug Alias NameBetaxolol Hydrochloride and Chlorthalidone氯噻酮/盐酸倍他洛尔Chlorthalidone/Betaxolol HydrochlorideKerledex
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAdrenergic receptors
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1992/10/30
Country/TerritoryUnited States
CombinationsYes Betaxolol HydrochlorideChlorthalidone
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeS01ED52
Related LinksN/A